Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression.


Journal

European journal of immunology
ISSN: 1521-4141
Titre abrégé: Eur J Immunol
Pays: Germany
ID NLM: 1273201

Informations de publication

Date de publication:
11 2019
Historique:
received: 02 11 2018
revised: 16 05 2019
accepted: 28 06 2019
pubmed: 4 7 2019
medline: 27 5 2020
entrez: 4 7 2019
Statut: ppublish

Résumé

DCs and epithelial cell-derived thymic stromal lymphopoietin (TSLP) have pivotal roles in allergic inflammation. TSLP stimulates myeloid DCs to express OX40-ligand (OX40L) and CCL17, which trigger and maintain Th2 cell responses. We have previously shown that statins, which are HMG-CoA reductase inhibitors, have the ability to suppress type I IFN production by plasmacytoid DCs. Here, we extended our previous work to examine the immunomodulatory effect of statins on allergic responses, particularly the TSLP-dependent Th2 pathway induced by myeloid DCs. We found that treatment of TSLP-stimulated DCs with either pitavastatin or simvastatin suppressed both the DC-mediated inflammatory Th2 cell differentiation and CRTH2

Identifiants

pubmed: 31269241
doi: 10.1002/eji.201847992
pmc: PMC6899642
doi:

Substances chimiques

Antibodies, Neutralizing 0
CCL17 protein, human 0
CD28 Antigens 0
CD3 Complex 0
Chemokine CCL17 0
Cytokines 0
Interleukins 0
NF-kappa B p50 Subunit 0
OX40 Ligand 0
Quinolines 0
TNFSF4 protein, human 0
Tumor Necrosis Factor-alpha 0
Interferon-gamma 82115-62-6
Simvastatin AGG2FN16EV
pitavastatin M5681Q5F9P
Thymic Stromal Lymphopoietin GT0IL38SP4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2051-2062

Informations de copyright

© 2019 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

Lancet Respir Med. 2014 Jun;2(6):455-63
pubmed: 24717640
Nat Rev Immunol. 2004 Jun;4(6):420-31
pubmed: 15173831
Nat Immunol. 2002 Jul;3(7):673-80
pubmed: 12055625
Nat Immunol. 2008 Dec;9(12):1341-6
pubmed: 18931678
J Eur Acad Dermatol Venereol. 2013 Feb;27(2):e197-205
pubmed: 22646697
Pulm Pharmacol Ther. 2005;18(1):67-74
pubmed: 15607129
J Immunol. 2008 Oct 15;181(8):5340-9
pubmed: 18832690
J Immunol. 2004 Dec 15;173(12):7565-74
pubmed: 15585884
Clin Exp Allergy. 2007 Apr;37(4):599-607
pubmed: 17430358
Immunity. 2006 Jun;24(6):673-5
pubmed: 16782024
Handb Exp Pharmacol. 2008;(181):257-88
pubmed: 18071950
J Clin Invest. 2007 Dec;117(12):3655-7
pubmed: 18074001
Pulm Med. 2015;2015:835204
pubmed: 26618001
J Exp Med. 2007 Aug 6;204(8):1837-47
pubmed: 17635955
Nat Immunol. 2010 Apr;11(4):289-93
pubmed: 20300138
Nature. 2002 Nov 7;420(6911):78-84
pubmed: 12422218
J Immunol. 2002 Aug 1;169(3):1524-34
pubmed: 12133980
J Immunol. 2001 Jul 1;167(1):336-43
pubmed: 11418668
Trends Mol Med. 2008 Jan;14(1):37-44
pubmed: 18068482
Immunity. 2006 Jun;24(6):827-38
pubmed: 16782037
Nat Immunol. 2012 Oct;13(10):981-90
pubmed: 22842344
J Immunol. 2006 Jul 1;177(1):651-6
pubmed: 16785563
J Exp Med. 2003 Jul 21;198(2):315-24
pubmed: 12860930
J Exp Med. 2000 Jan 17;191(2):365-74
pubmed: 10637280
J Exp Med. 2007 Feb 19;204(2):253-8
pubmed: 17242164
Allergol Int. 2014 Sep;63(3):443-55
pubmed: 24851948
J Leukoc Biol. 2006 Mar;79(3):529-38
pubmed: 16387846
Allergy. 2014 Aug;69(8):1068-76
pubmed: 24888572
Eur J Immunol. 2002 Oct;32(10):2874-80
pubmed: 12355440
J Drugs Dermatol. 2010 Aug;9(8):921-7
pubmed: 20684142
Nature. 1996 Oct 31;383(6603):787-93
pubmed: 8893001
Clin Exp Allergy. 2014 Jan;44(1):29-37
pubmed: 24224471
Immunology. 2009 Aug;127(4):450-8
pubmed: 19604299
J Exp Med. 2005 Nov 7;202(9):1213-23
pubmed: 16275760
Blood. 2006 Mar 15;107(6):2423-31
pubmed: 16293610
Annu Rev Immunol. 2007;25:193-219
pubmed: 17129180
J Clin Invest. 2000 Aug;106(4):551-9
pubmed: 10953030
Lancet. 2004 May 15;363(9421):1607-8
pubmed: 15145635
N Engl J Med. 2001 Feb 1;344(5):350-62
pubmed: 11172168
Arterioscler Thromb Vasc Biol. 2001 Jan;21(1):115-21
pubmed: 11145942
J Clin Pathol. 2001 Aug;54(8):577-89
pubmed: 11477111
Clin Exp Allergy. 1993 Jan;23(1):4-6
pubmed: 8439820
Arthritis Rheum. 2006 Feb;54(2):579-86
pubmed: 16447234
Nat Immunol. 2010 Aug;11(8):647-55
pubmed: 20644570
N Engl J Med. 1995 Sep 7;333(10):621-7
pubmed: 7637722
Drug Discov Today. 2017 Apr;22(4):702-711
pubmed: 27956056
J Dermatol. 2014 Mar;41(3):221-9
pubmed: 24628072
Nat Rev Immunol. 2006 Nov;6(11):869-74
pubmed: 17063187
Annu Rev Immunol. 1989;7:145-73
pubmed: 2523712
BMJ. 2000 Jan 22;320(7229):231-4
pubmed: 10642235
J Immunol. 2002 Nov 1;169(9):4788-96
pubmed: 12391188
Nature. 1990 Feb 1;343(6257):425-30
pubmed: 1967820
Respir Res. 2012 Nov 24;13:108
pubmed: 23176705
Immunity. 1999 Dec;11(6):689-98
pubmed: 10626891
Clin Exp Allergy. 2015 Dec;45(12):1812-22
pubmed: 26245530
J Allergy Clin Immunol. 2001 Jun;107(6):963-70
pubmed: 11398072
Sci Signal. 2010 Jan 19;3(105):ra4
pubmed: 20086239
J Allergy Clin Immunol. 2007 Aug;120(2):238-44; quiz 245-6
pubmed: 17666213
Arthritis Rheum. 2010 Jul;62(7):2073-85
pubmed: 20506142
J Immunol. 1999 Aug 1;163(3):1409-19
pubmed: 10415041
Nat Rev Immunol. 2006 May;6(5):358-70
pubmed: 16639429
J Immunol. 2004 Dec 15;173(12):7641-6
pubmed: 15585892
Arthritis Res Ther. 2014 Nov 30;16(6):497
pubmed: 25433812
BMJ Open. 2013 Aug 13;3(8):null
pubmed: 23943778
Annu Rev Immunol. 1997;15:297-322
pubmed: 9143690
Lancet. 1999 Jan 16;353(9148):196-200
pubmed: 9923875

Auteurs

Noriko Inagaki-Katashiba (N)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Tomoki Ito (T)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Muneo Inaba (M)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Yoshiko Azuma (Y)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Akihiro Tanaka (A)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Vien Phan (V)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Kayoko Kibata (K)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Atsushi Satake (A)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Shosaku Nomura (S)

First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, 573-1191, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH